ErlySign Raises Rs 16 Crore to Transform Oral Cancer Detection with a Simple Saliva Test
In a breakthrough for cancer diagnostics, ErlySign, formerly known as CURO Biosciences, has secured Rs 16 crore in a pre-Series A funding round led by renowned investor Ashish Kacholia. This exciting investment will fast-track the startup’s mission to launch a groundbreaking oral cancer detection kit that…
